Guangdong VTR Bio-Tech Co., Ltd. (300381.SZ)
CNY 8.04
(1.9%)
CNY 8.04
(1.9%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 359.78 Million CNY | 0.99% |
| 2022 | 356.26 Million CNY | -75.12% |
| 2021 | 1.43 Billion CNY | 1.61% |
| 2020 | 1.4 Billion CNY | -21.24% |
| 2019 | 1.78 Billion CNY | -25.27% |
| 2018 | 2.39 Billion CNY | 36.43% |
| 2017 | 1.75 Billion CNY | 51.93% |
| 2016 | 1.15 Billion CNY | 11.43% |
| 2015 | 1.03 Billion CNY | 272.93% |
| 2014 | 277.98 Million CNY | 294.94% |
| 2013 | 70.38 Million CNY | 31.2% |
| 2012 | 53.64 Million CNY | -24.73% |
| 2011 | 71.27 Million CNY | -15.11% |
| 2010 | 83.96 Million CNY | 18.08% |
| 2009 | 71.1 Million CNY | -2.25% |
| 2008 | 72.74 Million CNY | 57.44% |
| 2007 | 46.2 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 265.27 Million CNY | -5.51% |
| 2024 Q3 | 286.3 Million CNY | 7.93% |
| 2024 Q1 | 280.75 Million CNY | -21.97% |
| 2023 FY | 359.78 Million CNY | 0.99% |
| 2023 Q4 | 359.78 Million CNY | 33.21% |
| 2023 Q2 | 271.35 Million CNY | -16.67% |
| 2023 Q1 | 325.63 Million CNY | -8.6% |
| 2023 Q3 | 270.08 Million CNY | -0.47% |
| 2022 Q3 | 261.09 Million CNY | -5.07% |
| 2022 Q2 | 275.04 Million CNY | -82.1% |
| 2022 Q1 | 1.53 Billion CNY | 7.29% |
| 2022 FY | 356.26 Million CNY | -75.12% |
| 2022 Q4 | 356.26 Million CNY | 36.45% |
| 2021 Q3 | 1.37 Billion CNY | 2.88% |
| 2021 Q2 | 1.33 Billion CNY | -2.75% |
| 2021 Q1 | 1.37 Billion CNY | -2.75% |
| 2021 FY | 1.43 Billion CNY | 1.61% |
| 2021 Q4 | 1.43 Billion CNY | 4.42% |
| 2020 Q3 | 1.47 Billion CNY | -5.82% |
| 2020 Q1 | 1.87 Billion CNY | 4.97% |
| 2020 FY | 1.4 Billion CNY | -21.24% |
| 2020 Q2 | 1.56 Billion CNY | -16.76% |
| 2020 Q4 | 1.4 Billion CNY | -4.28% |
| 2019 FY | 1.78 Billion CNY | -25.27% |
| 2019 Q1 | 1.99 Billion CNY | -16.71% |
| 2019 Q2 | 1.99 Billion CNY | -0.12% |
| 2019 Q4 | 1.78 Billion CNY | -7.3% |
| 2019 Q3 | 1.93 Billion CNY | -3.1% |
| 2018 Q2 | 2.07 Billion CNY | 7.15% |
| 2018 Q3 | 2.07 Billion CNY | -0.15% |
| 2018 FY | 2.39 Billion CNY | 36.43% |
| 2018 Q4 | 2.39 Billion CNY | 15.38% |
| 2018 Q1 | 1.93 Billion CNY | 10.51% |
| 2017 Q4 | 1.75 Billion CNY | 17.88% |
| 2017 Q2 | 1.35 Billion CNY | 1.75% |
| 2017 Q1 | 1.32 Billion CNY | 15.11% |
| 2017 FY | 1.75 Billion CNY | 51.93% |
| 2017 Q3 | 1.48 Billion CNY | 10.03% |
| 2016 Q3 | 1.13 Billion CNY | -18.26% |
| 2016 Q2 | 1.38 Billion CNY | 22.64% |
| 2016 FY | 1.15 Billion CNY | 11.43% |
| 2016 Q1 | 1.12 Billion CNY | 8.87% |
| 2016 Q4 | 1.15 Billion CNY | 2.1% |
| 2015 Q2 | 201.66 Million CNY | 6.09% |
| 2015 FY | 1.03 Billion CNY | 272.93% |
| 2015 Q4 | 1.03 Billion CNY | 60.88% |
| 2015 Q3 | 644.38 Million CNY | 219.54% |
| 2015 Q1 | 190.08 Million CNY | -31.62% |
| 2014 Q2 | 50.08 Million CNY | 2.78% |
| 2014 Q1 | 48.72 Million CNY | -30.77% |
| 2014 Q4 | 277.98 Million CNY | 335.93% |
| 2014 Q3 | 63.76 Million CNY | 27.33% |
| 2014 FY | 277.98 Million CNY | 294.94% |
| 2013 Q4 | 70.38 Million CNY | 37.94% |
| 2013 FY | 70.38 Million CNY | 31.2% |
| 2013 Q1 | - CNY | -100.0% |
| 2013 Q2 | 53.16 Million CNY | 0.0% |
| 2013 Q3 | 51.02 Million CNY | -4.03% |
| 2012 Q4 | 53.64 Million CNY | 0.0% |
| 2012 FY | 53.64 Million CNY | -24.73% |
| 2011 FY | 71.27 Million CNY | -15.11% |
| 2010 Q3 | 70.45 Million CNY | 0.0% |
| 2010 FY | 83.96 Million CNY | 18.08% |
| 2010 Q4 | 83.96 Million CNY | 19.16% |
| 2009 FY | 71.1 Million CNY | -2.25% |
| 2008 FY | 72.74 Million CNY | 57.44% |
| 2007 FY | 46.2 Million CNY | 0.0% |